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Abstract
Background: Although the comorbidity of migraine and restless legs syndrome (RLS) has been well-documented,
the association between RLS and migraine frequency has yet to be elucidated. The present study aims to evaluate
the prevalence of RLS among individuals who experience low-frequency, high-frequency, or chronic migraine
presenting with and without aura.
Methods: We conducted a cross-sectional, case-controlled study involving 505 participants receiving outpatient
headache treatment. Standardized questionnaires were administered to collect information on experiences of
migraine, RLS, sleep quality, anxiety, depression, and demographics. Participants were categorized into low-frequency
(1–8/month), high-frequency (9–14/month), and chronic (≥15/month) headache groups. RLS was diagnosed according
to the criteria outlined by the International RLS Study Group (IRLSSG). The Pittsburgh Sleep Quality Index (PSQI) and
Hospital Anxiety and Depression Scale (HADS) were used to assess sleep quality and identify symptoms of anxiety and
depression. Associations between migraine frequency and RLS prevalence were investigated using multivariate linear
and logistic regression.
Results: Univariate analysis revealed an effect of migraine frequency on RLS prevalence (p = 0.026), though this effect
did not persist following adjustment for baseline characteristics (p = 0.256). The trend was robust in patients whose
migraines presented with auras (punivariate = 0.002; pmultivariate = 0.043) but not in those without auras (punivariate and
pmultivariate > 0.05). Higher anxiety [odds ratio (OR) = 1.18, p = 0.019] and sleep disturbance (OR = 1.17, p = 0.023) scores
were associated with higher RLS prevalence.
Conclusions: Higher migraine frequency correlates with a higher prevalence of RLS, particularly among
patients with auras.
Keywords: Migraine, Restless legs syndrome, Iron metabolism, Dopamine, Hospital anxiety and depression
subscales, Pittsburgh sleep quality index
Background
Migraine is a primary headache disorder that affects
10 ~ 20 % of the general population. The disorder is
typically characterized by recurrent attacks of moderate-
to-severe pulsating pain on one side of the head that may
last anywhere from 4 to 72 hours. Migraine pain is often
associated with photophobia, phonophobia, and/or
nausea and vomiting, and may be further aggravated by
physical activity [1, 2]. Research has revealed comorbid-
ity of migraine and numerous other conditions, includ-
ing cardiovascular disease, asthma, depression, stroke,
epilepsy, and a number of other pain disorders [3–6].
In addition, migraineurs have been reported to have a
higher than normal prevalence of sleep disorders, in-
cluding the sleep-related movement disorder restless
legs syndrome (RLS) [7, 8].
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RLS, for which reported prevalence rates vary from 4 %
to 29 % in the general population, is characterized by an
unpleasant leg sensation that typically worsens at night
and resolves with movement [9]. Approximately 70 % of
RLS cases are primary idiopathic forms, perhaps related to
some genetic predisposition, while the remaining cases are
symptomatic of another primary condition, such as iron
deficiency anemia, renal failure, depression, pregnancy,
migraine, or even Parkinson’s disease [10]. Although the
pathophysiology of RLS remains unclear [11, 12], current
research indicates that dysfunction of the hypothalamic
dopaminergic A11 nucleus may be involved [13]. Dopa-
mine has also been implicated in migraine pathophysi-
ology, especially with regard to premonitory symptoms
such as yawning, food cravings, and gastrointestinal
disturbances [14]. Interestingly, migraineurs with RLS
more often experience premonitory symptoms than
those without RLS, further supporting the notion of a
dopaminergic link between migraine and RLS [15]. In
addition, iron deposition in multiple deep brain nuclei
has been addressed in migraineurs [16, 17], though not
in those with RLS. Moreover, spreading reductions in
cerebral blood flow have been associated with migraine
aura pathophysiology [18]. Additionally, research suggests
that the depolarization of neurons and glial propagation in
a wave-like manner across susceptible brain regions may
be related to both migraine aura and RLS [19].
Previously reported prevalence rates of RLS in migraine
patients have ranged from 8.7 % to 39.0 % [20, 21], with
no significant differences between migraineurs with aura
(MAs) and migraineurs without aura (MOs) [12, 22, 23].
Although research regarding the relationship between
RLS and migraine frequency is limited, Cho et al. [24]
have reported similarly increased prevalence rates of RLS
among migraineurs who experience between one and ten
attacks per month relative to those observed among
migraineurs experiencing fewer than one attack per
month. However, participants in the Cho et al. study were
not divided into separate MA and MO groups.
Among migraine patients, RLS comorbidity has been
observed to be associated with poorer sleep quality [12].
Additionally, the authors of the present study previously
reported that higher migraine frequency is correlated with
poorer sleep quality in both MA and MO patients [25].
The aim of the present study was to determine whether
higher migraine frequency is correlated with increased
prevalence of RLS and, if so, whether the relationship be-
tween migraine frequency and RLS prevalence differs be-
tween patients with MA and MO.
Methods
Patients
A cross-sectional controlled study was conducted with a
cohort of 505 participants undergoing outpatient
monitoring through the Department of Neurology at Tri-
Service General Hospital (TSGH) between January of
2014 and December of 2015. The study protocol received
approval from the Institutional Review Board of TSGH,
and all participants provided informed written consent
prior to enrollment.
Each participant completed a screening questionnaire
and was subsequently interviewed by a board-certified
neurologist and headache specialist (FCY) who made a
diagnosis based on criteria defined in the International
Classification of Headache Disorders, 3rd edition (ICHD-
III beta) [2]. Participants also completed the Migraine
Disability Assessment Questionnaire (MIDAS), which is
a 5-item questionnaire used to evaluate disability over
the last 3 months [26]. The participants were then di-
vided into the following four study groups: chronic
headaches (≥15/month; N = 57), high-frequency head-
aches (9–14/month; N = 91), low-frequency headaches
(1–8/month; N = 224), and migraine-free controls with
no history of primary or secondary headache disorders
(N = 133). Of the 372 participants with migraine, 111




RLS was diagnosed according to the following five es-
sential diagnostic criteria outlined by the International
RLS Study Group [27]: (1) urge to move the legs that is
usually accompanied by unpleasant sensations in the
legs; (2) urge to move or uncomfortable sensations that
begin or worsen during periods of rest, including lying
down or sitting; (3) urge to move or uncomfortable sen-
sations that are relieved partially or totally by leg move-
ment; (4) urge to move or uncomfortable sensations that
worsen in the early evening or night compared with day-
time, or occur only in the evening or at night; and (5)
the inability of other medical or behavioral conditions
(e.g., venous stasis, leg edema, myalgia, arthritis, pos-
itional discomfort, habitual foot tapping, leg cramps) to
account for the aforementioned features.
None participants reported any history of physical,
cognitive, or degenerative diseases of the central nervous
system, or severe head injuries with loss of consciousness.
All participants underwent detailed neurologic and elec-
tromyography examinations, as well as Doppler ultra-
sound examination by an experienced radiologist, in order
to screen for any disturbances in the venous drainage of
the lower extremities. No definitive abnormalities were
identified for any of the patients. Patients exhibiting
common potential causes for secondary RLS, including
anemia, blood ferritin < 50 ng/ml, blood creatinine
>1.5 mg/dl, and pregnancy, were also excluded. Diagnoses
of idiopathic RLS were supported by physical, neurologic,
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electromyography, and radiologic examinations and la-
boratory data.
Assessment of anxiety and depression
The Hospital Anxiety and Depression Scale (HADS) [28]
is a 14-item scale used to assess symptoms of anxiety
(7 items) and depression (7 items). Each item is scored
from 0 to 3 (0 = not at all; 1 = sometimes; 2 = often; and 3
= all the time), yielding total possible scores within the
range of 0–21 for anxiety and 0–21 for depression. We
adopted the cut-off point of 8/21 for either anxiety or de-
pression utilized by Bjelland et al [29].
Quantification of sleep quality
The Pittsburgh Sleep Quality Index (PSQI) [30],
which includes 19 self-rated items distributed among
seven components, is designed to assess an individ-
ual’s quality of sleep during the past month; total
PSQI scores (range: 0–21) ≥6 were considered indica-
tive of sleep disturbance. Although we utilized the
Chinese version of the MIDAS, HADS, and PSQI in
the present study [31–33], each has been validated in
a number of published studies [25, 34, 35].
Data analysis
Data obtained for continuous covariates are presented as
means ± standard deviations (SDs), while data obtained
for categorical covariates are reported as numbers with
proportions. Odds ratios (ORs) are reported with 95 %
confidence intervals (CIs). The Cochran-Armitage chi-
square test and univariate linear regression were used to
investigate potential trends with regard to categorical
and continuous covariates, respectively, in relation to
the four group designations. The hypothesized relation-
ship between migraine frequency and RLS prevalence
was investigated using univariate analysis (the Cochran-
Armitage chi-square test) as well as linear contrast in a
multivariate logistic regression analysis adjusted for sub-
ject characteristics (variables listed in Table 1, except for
aura and MIDAS). Finally, we employed both univariate
and multivariable logistic regression analyses to deter-
mine which factors were associated with RLS prevalence.
Data analyses were conducted with SPSS Version 22
(IBM SPSS, Armonk, NY: IBM Corp).
Results
Participant characteristics
The demographic and clinical characteristics of partici-
pants in each study group are summarized in Table 1.











Aura - 71 (31.7) 23 (25.3) 17 (29.8) 0.526
Female gender 89 (66.9) 150 (67.0) 64 (70.3) 39 (68.4) 0.666
Age (years) 35.4 ± 12.6 33.1 ± 10.2 33.5 ± 10.3 32.7 ± 12.4 0.165
Body mass index (kg/m2) 23.2 ± 4.0 22.0 ± 3.4 22.5 ± 4.0 22.4 ± 4.0 0.319
Education level (years) 14.6 ± 2.5 14.6 ± 2.6 14.5 ± 2.5 14.2 ± 2.9 0.315
Smoking status 0.001
Never 130 (97.7) 171 (76.3) 71 (78.0) 46 (80.7)
Current or Former 3 (2.3) 53 (23.7) 20 (22.0) 11 (19.3)
Alcohol consumption 0.098
Never 106 (79.7) 133 (59.4) 62 (68.1) 38 (66.7)
Current or Former 27 (20.3) 91 (40.6) 29 (31.9) 19 (33.3)
Coffee consumption 0.005
Never 53 (39.8) 52 (23.2) 24 (26.4) 10 (17.5)
Less than once a month 39 (29.3) 43 (19.2) 23 (25.3) 21 (36.8)
At least 1 day a week 41 (30.8) 129 (57.6) 44 (48.4) 26 (45.6)
MIDAS - 24.5 ± 19.3 37.6 ± 25.5 68.8 ± 58.1 <0.001
HADS–anxiety 6.0 ± 3.6 7.7 ± 3.9 8.3 ± 4.1 8.9 ± 4.6 <0.001
HADS–depression 4.6 ± 3.0 5.3 ± 3.9 6.6 ± 3.9 7.2 ± 4.6 <0.001
PSQI total score 7.4 ± 3.0 8.4 ± 3.5 10.0 ± 3.5 9.8 ± 4.4 <0.001
§Linear trend Cochran–Armitage chi-square test for categorical variables; linear contrast of univariate linear regression for continuous variables
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Overall, less than a third of the patients experienced
auras (111/372; 29.8 %). No trends in the distributions
of gender, age, body mass index, education level, or alco-
hol consumption across the study groups were detected.
Linear trend analyses (unadjusted) revealed that more
frequent migraine headaches correlated with higher
MIDAS, HADS anxiety, and HADS depression scores,
as well as with total PSQI score. Participants in the
control group were less likely to be smokers and con-
sumed coffee less often than participants in the mi-
graine groups (Table 1).
Effect of migraine frequency on RLS prevalence
The results of our analyses of the relationship between
headache frequency group and RLS are reported in
Table 2. Briefly, our univariate analysis revealed an effect
of migraine frequency on total RLS prevalence (whole
cohort), though the effect was no longer significant after
adjusting for baseline characteristics. When we stratified
the participants in the migraine groups into subgroups
according to the presence of aura (i.e., MA and MO), we
observed a robust significant relationship between mi-
graine frequency and RLS prevalence in MA subgroups,
but not in MO subgroups (Table 2). The total RLS
prevalence rates for the headache frequency-delineated
study groups as well as for the MA and MO subgroups
are reported in Fig. 1a and 1b, respectively.
Factors associated with RLS prevalence
The results of univariate and multivariate analyses aimed
at elucidating those factors associated with RLS
prevalence are reported in Table 3. The univariate
analyses revealed that participants in the chronic mi-
graine frequency group (≥15 days/month) were more
likely to experience RLS than control participants.
Higher HADS anxiety scores and total PSQI scores
were also associated with higher RLS prevalence; both
associations remained significant after adjusting for
baseline characteristics (Table 3).
Discussion
In the present study, we observed that increased RLS
prevalence was associated with migraine frequency
(based on number of headache days per month), utiliz-
ing an age- and gender-matched control group for the
analysis. RLS prevalence correlated strongly with mi-
graine frequency group in patients with MA after adjust-
ing for well-known confounding variables (i.e., age,
gender, body mass index, education level, smoking sta-
tus, alcohol consumption, coffee consumption, MIDAS
score, HADS anxiety score, HADS depression score, and
total PSQI score). RLS prevalence was also associated
with HADS anxiety score and PSQI total score.
In a recent nationwide, population-based cohort study
conducted in Taiwan, we detected an increased risk of
RLS in patients with migraine when compared with
non-migraineurs, regardless of comorbidities or mi-
graine subtype [36]. Further, Ferreira et al. [37] observed
that RLS prevalence was higher in patients with mi-
graine than in controls in a Brazilian cohort, though they
did not analyze whether RLS prevalence differed with re-
spect to presence of auras or headache attack frequency,
for which the sample sizes were likely too small to pro-
vide sufficient power. More recently, a large population-
based study that collected data from approximately 2300
patients has indicated that RLS is more prevalent and
more severe in patients with migraine, and is also as-
sociated with poorer sleep quality. However, condi-
tions mimicking RLS could not be excluded, which
may have influenced the results [38, 39]. The results
of the present study, consistent with those of previous
studies [7, 8, 36–39], indicate that migraineurs have a











Whole cohort (N = 505) 0.026 0.256
Non-RLS 128 (96.2) 213 (95.1) 85 (93.4) 50 (87.7)
RLS 5 (3.8) 11 (4.9) 6 (6.6) 7 (12.3)
With aura (N = 244) 0.002 0.043
Non-RLS 128 (96.2) 66 (93.0) 20 (87.0) 13 (76.5)
RLS 5 (3.8) 5 (7.0) 3 (13.0) 4 (23.5)
Without aura (N = 394) 0.385 0.750
Non-RLS 128 (96.2) 147 (96.1) 65 (95.6) 37 (92.5)
RLS 5 (3.8) 6 (3.9) 3 (4.4) 3 (7.5)
†Linear trend analysis by Cochran–Armitage chi-square test (unadjusted analysis);
§Linear contrast in the multivariable logistic regression with adjustment of gender, age, body mass index, education level, smoking status, alcohol consumption,
coffee consumption, HADS anxiety, HADS depression, and PSQI score
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higher prevalence of RLS than controls. Further, we
observed particularly high RLS prevalence for patients
with MA as well as an association between RLS preva-
lence and higher frequency of headaches.
These findings contrast with those of previous studies
that have reported similar RLS prevalence rates between
patients with MA (8.3–33.3 %) and MO (0.9–32.2 %)
[12, 22, 23]. Also contrary to the findings of our study,
Onofrio et al. reported that the RLS prevalence rate in pa-
tients with MA was similar to that of non-migraineur con-
trols in Italy and that patients with MA and RLS seemed
to have fewer attacks per month than patients with MA
who do not have RLS, though the sample size (MA group
N = 63) was relatively small [40, 41]. The aforementioned
result discrepancies across studies may be related, at least
in part, to differences in the populations examined. Indeed,
the annual RLS incidence rate among non-migraineur con-
trols (3.42/10,000 person-y) in our previous nationwide
Taiwanese study was lower than that reported in a German
cohort study (9–22/10,000 person-y) [36]. Moreover, in a
systemic review, Schürks and colleagues observed lower
RLS prevalence rates among Asians (1.8–5.6 %) than non-
Asians (5.6–12.0 %) [9]. Therefore, the findings of the
present study should be interpreted cautiously in recogni-
tion of potential differences in population ethnicities, as
well as differences in methodology and clinical setting.
The reported associations between smoking/caffeine
consumption and higher migraine frequency support the
Fig. 1 a RLS prevalence across the study groups. b RLS prevalence
stratified by aura or no aura across the study groups.
Table 3 Factors associating with RLS prevalence
Variable Univariate analysis Multivariable analysis
OR (95 % CI) p value OR (95 % CI) p value
Migraine frequency
Control (reference) - -
1–8 days 1.32 (0.45–3.89) 0.612 1.03 (0.29–3.71) 0.963
9–14 days 1.81 (0.54–6.11) 0.341 1.21 (0.30–4.88) 0.791
≥ 15 days 3.58 (1.09–11.82) 0.036 2.34 (0.56–9.83) 0.246
Female gender 0.94 (0.43–2.05) 0.874 0.87 (0.35–2.18) 0.763
Age (years) 1.01 (0.98–1.04) 0.547 1.02 (0.98–1.06) 0.374
Body mass index (kg/m2) 1.02 (0.93–1.13) 0.663 1.00 (0.90–1.11) 0.946
Education level (years) 0.96 (0.84–1.10) 0.568 1.02 (0.88–1.19) 0.762
Current or former smoker 1.23 (0.49–3.10) 0.663 0.98 (0.33–2.96) 0.973
Current or former alcohol 1.86 (0.89–3.92) 0.100 1.55 (0.63–3.84) 0.340
Coffee consumption
Never (reference) - -
< once a month 0.71 (0.24–2.04) 0.518 0.59 (0.17–2.03) 0.402
≥ 1 day a week 0.96 (0.41–2.25) 0.923 0.97 (0.36–2.61) 0.947
HADS-anxiety 1.20 (1.09–1.31) <0.001 1.18 (1.03–1.36) 0.019
HADS-depression 1.08 (0.99–1.18) 0.083 0.89 (0.78–1.02) 0.094
PSQI total score 1.26 (1.13–1.39) <0.001 1.17 (1.02–1.33) 0.023
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notion that both smoking and caffeine consumption may
be significant triggers of migraine attacks [42]. Additionally,
the observed linear trends between HADS scores and higher
migraine frequency in the present study align with the claim
that depression (63.8 %) and anxiety (60.4 %) are the most
common comorbid conditions of migraine [43]. Further-
more, the observed association between migraine frequency
and sleep disturbance (i.e., PSQI score) in the present study
is consistent with the Vgontzas et al. finding that 48.8 % of
patients with migraine experience some form of sleep dis-
turbance, even after controlling for anxiety (lifetime and
current) and the presence of other mood disorders [44].
Multivariate regression analyses indicated that anxiety
(HADS anxiety score) and sleep disturbance (PSQI total
score) were each an independent predictor of RLS preva-
lence (Table 3), with the latter result corroborating our
previous finding that RLS is an independent predictor of
poor sleep quality (PSQI total score ≥ 6) [25]. Therefore,
it seems highly likely that RLS and poor sleep quality act
to exacerbate each other.
Though Sevim et al. [45] observed a correlation between
RLS severity and the severity of anxiety/depression symp-
toms, positing that disorders of anxiety and depression
may be related to RLS symptoms, the results of the present
study suggest a relationship between RLS and anxiety, but
not depression. However, the present study utilized the
HADS to assess symptoms of anxiety and depression,
whereas Sevim and colleagues conducted diagnostic inter-
views. Further research is certainly warranted regarding
RLS and comorbid anxiety and depression disorders.
Several lines of evidence suggest that the clinical fea-
tures and underlying pathophysiology of both RLS and
migraine may be related. Iron deposition in the brain
has been reported in migraineurs, and repeated attacks
have associated with increased levels of iron [46]. Con-
versely, iron deficiency has been implicated in the patho-
physiology of RLS [11]. Further, dopamine-mediated
premonitory symptoms [14] have been more commonly
reported in patients with migraine and comorbid RLS
than in patients with migraine and no RLS [15], and
dopamine receptor antagonism can abort migraine
attacks [47]. Meanwhile, central dysfunction of dopamin-
ergic hypothalamo-spinal (A11) neurons has been strongly
implicated in the pathophysiology of RLS, and the dopa-
minergic hypothesis has been supported by observation of
beneficial effects of dopamine receptor agonist therapy on
RLS symptoms [13]. Finally, a genetic analysis study by
Fuh et al. [48] observed that presence of the Meis homeo-
box 1 gene was associated with increased risk of RLS in
migraineurs and in patients with MA specifically.
The results of the present study have significant clin-
ical implications. RLS, in and of itself, may impair sleep
quality, which could play a direct role in the develop-
ment of chronic migraine disorders. Furthermore, given
that chronic migraine can not only be highly disabling
and exert a significant negative impact on quality of life
but also increase the relative socioeconomic burden as-
sociated with patient care [49], alleviation of RLS in
migraineurs may improve quality of life and potentially
prevent the development of chronic migraine in patients
with episodic headaches [8]. Hence, the present study re-
inforces the need to identify potential cases of RLS in
patients with migraine—particularly in patients with MA
who have high-frequency attacks—in order to provide
the most appropriate and effective treatments.
The strengths of the present study are its well-
controlled design, demographically homogenous groups,
analysis of MA versus MO subgroups, and robust statis-
tical analysis. However, the study also had some limita-
tions. First, the cross-sectional design restricts the causal
relationship between migraine and RLS. Second, RLS
prevalence (in Table 3) was established based simply on
IRLSSG diagnostic criteria without consideration of se-
verity. Third, sleep quality was evaluated using a self-
reported index rather than an objective assessment. The
mean PSQI score for our controls (7.4 ± 3.0; poor sleepers
75.4 %, data not shown) was higher than that reported by
Seidel et al. [50] but similar to prior data from Taiwanese
patients (6.1 ± 2.2; poor sleepers, 60.8 %) [51]. Finally, the
relatively small numbers of participants in the chronic
frequency group and MA patient subgroups may have
reduced the potential to observe additional associations.
Indeed, the relatively small cohort size in our study limited
our ability to examine more differentiated subgroups, con-
sidering the interaction or influence by other migraine co-
morbidities, such as cardiovascular disorders, psychiatric
conditions, obesity, epilepsy, fibromyalgia, and asthma
[3–6, 52]. Therefore, future studies involving larger
cohort sizes with more differentiated subgroups aid
researchers in understanding the associations among
various aspects and comorbidities of migraine.
Conclusions
In conclusion, the results of the present study revealed a
significant association between RLS prevalence and
higher migraine frequency in patients with MA. The re-
sults further demonstrated that higher HADS anxiety
scores and total PSQI scores were associated with higher
RLS prevalence. Further, interventions targeted toward
preventing the evolution of episodic disorders into
chronic migraine conditions might reduce the tendency
for comorbid RLS, particularly in patients with MA.
Future studies should investigate those factors that relate
RLS and migraine and aim to clarify the relationship
between RLS severity and anxiety/depression.
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